BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11040186)

  • 21. Immunogenicity of two oat varieties, in relation to their safety for celiac patients.
    Maglio M; Mazzarella G; Barone MV; Gianfrani C; Pogna N; Gazza L; Stefanile R; Camarca A; Colicchio B; Nanayakkara M; Miele E; Iaquinto G; Giardullo N; Maurano F; Santoro P; Troncone R; Auricchio S
    Scand J Gastroenterol; 2011 Oct; 46(10):1194-205. PubMed ID: 21843037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of IL-17A-producing cells in celiac disease mucosa.
    Monteleone I; Sarra M; Del Vecchio Blanco G; Paoluzi OA; Franzè E; Fina D; Fabrizi A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2010 Feb; 184(4):2211-8. PubMed ID: 20061410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity.
    Hollon J; Puppa EL; Greenwald B; Goldberg E; Guerrerio A; Fasano A
    Nutrients; 2015 Feb; 7(3):1565-76. PubMed ID: 25734566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody.
    Przemioslo RT; Lundin KE; Sollid LM; Nelufer J; Ciclitira PJ
    Gut; 1995 Jun; 36(6):874-9. PubMed ID: 7615276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.
    Kooy-Winkelaar YM; Bouwer D; Janssen GM; Thompson A; Brugman MH; Schmitz F; de Ru AH; van Gils T; Bouma G; van Rood JJ; van Veelen PA; Mearin ML; Mulder CJ; Koning F; van Bergen J
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E980-E989. PubMed ID: 28049849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease.
    Kalliomäki M; Satokari R; Lähteenoja H; Vähämiko S; Grönlund J; Routi T; Salminen S
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):727-32. PubMed ID: 22134550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic evidence of no harmful effect of oats in celiac disease.
    Picarelli A; Di Tola M; Sabbatella L; Gabrielli F; Di Cello T; Anania MC; Mastracchio A; Silano M; De Vincenzi M
    Am J Clin Nutr; 2001 Jul; 74(1):137-40. PubMed ID: 11451729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease.
    Olaussen RW; Løvik A; Tollefsen S; Andresen PA; Vatn MH; De Lange T; Bratlie J; Brandtzaeg P; Farstad IN; Lundin KE
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):875-85. PubMed ID: 16234025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4.
    Troncone R; Gianfrani C; Mazzarella G; Greco L; Guardiola J; Auricchio S; De Berardinis P
    Dig Dis Sci; 1998 Jan; 43(1):156-61. PubMed ID: 9508518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells.
    Gianfrani C; Levings MK; Sartirana C; Mazzarella G; Barba G; Zanzi D; Camarca A; Iaquinto G; Giardullo N; Auricchio S; Troncone R; Roncarolo MG
    J Immunol; 2006 Sep; 177(6):4178-86. PubMed ID: 16951383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease.
    Esposito G; Cirillo C; Sarnelli G; De Filippis D; D'Armiento FP; Rocco A; Nardone G; Petruzzelli R; Grosso M; Izzo P; Iuvone T; Cuomo R
    Gastroenterology; 2007 Sep; 133(3):918-25. PubMed ID: 17678654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.
    Martucci S; Fraser JS; Biagi F; Corazza GR; Ciclitira PJ; Ellis HJ
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1293-8. PubMed ID: 14624152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal parameters of oxidative imbalance in celiac adults with extraintestinal manifestations.
    Piatek-Guziewicz A; Ptak-Belowska A; Przybylska-Felus M; Pasko P; Zagrodzki P; Brzozowski T; Mach T; Zwolinska-Wcislo M
    World J Gastroenterol; 2017 Nov; 23(44):7849-7862. PubMed ID: 29209126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture.
    Kilmartin C; Lynch S; Abuzakouk M; Wieser H; Feighery C
    Gut; 2003 Jan; 52(1):47-52. PubMed ID: 12477758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase pattern in celiac duodenal mucosa.
    Ciccocioppo R; Di Sabatino A; Bauer M; Della Riccia DN; Bizzini F; Biagi F; Cifone MG; Corazza GR; Schuppan D
    Lab Invest; 2005 Mar; 85(3):397-407. PubMed ID: 15608660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.
    Ferguson A; MacDonald TT; McClure JP; Holden RJ
    Lancet; 1975 Apr; 1(7912):895-7. PubMed ID: 47539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
    Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
    Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies.
    Stallmach A; Belitz HD; Gellermann B; Schäfer H; Wieser H; Stern M
    J Pediatr Gastroenterol Nutr; 1987; 6(3):335-40. PubMed ID: 3430242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.
    Barone MV; Troncone R; Auricchio S
    Int J Mol Sci; 2014 Nov; 15(11):20518-37. PubMed ID: 25387079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.
    Ciszewski C; Discepolo V; Pacis A; Doerr N; Tastet O; Mayassi T; Maglio M; Basheer A; Al-Mawsawi LQ; Green PHR; Auricchio R; Troncone R; Waldmann TA; Azimi N; Tagaya Y; Barreiro LB; Jabri B
    Gastroenterology; 2020 Feb; 158(3):625-637.e13. PubMed ID: 31622625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.